TY  - JOUR
AU  - Navarro, Paloma
AU  - Bueno, Maria J
AU  - Zagorac, Ivana
AU  - Mondejar, Tamara
AU  - Sanchez, Jesus
AU  - Mouron, Silvana Andrea
AU  - Muoz Peralta, Javier
AU  - Gómez-López, Gonzalo
AU  - Jimenez-Renard, Veronica
AU  - Mulero Francisca, F
AU  - Chandel, Navdeep S
AU  - Quintela Fandino, Miguel Angel
PY  - 2016
DO  - 10.1016/j.celrep.2016.05.052
SN  - 22111247
UR  - http://hdl.handle.net/20.500.12105/7891
AB  - Epithelial malignancies are effectively treated by antiangiogenics; however, acquired resistance is a major problem in cancer therapeutics. Epithelial tumors commonly have mutations in the MAPK/Pi3K-AKT pathways, which leads to high-rate aerobic...
LA  - eng
PB  - Cell Press
KW  - Angiogenesis Inhibitors
KW  - Animals
KW  - Cell Proliferation
KW  - Cell Respiration
KW  - Cellular Reprogramming
KW  - Disease Models, Animal
KW  - Down-Regulation
KW  - Drug Resistance, Neoplasm
KW  - Fatty Acids
KW  - Female
KW  - Glucose
KW  - Glycolysis
KW  - Humans
KW  - Ketone Bodies
KW  - Metabolome
KW  - Mice, Inbred C57BL
KW  - Mice, Nude
KW  - Mitochondria
KW  - Mitochondrial Degradation
KW  - Neoplasms
KW  - Oxygen
KW  - Phenylurea Compounds
KW  - Phosphoproteins
KW  - Protein Kinase Inhibitors
KW  - Pyridines
KW  - Signal Transduction
TI  - Targeting Tumor Mitochondrial Metabolism Overcomes Resistance to Antiangiogenics
TY  - journal article
ER  -